Charikleia Christakou

Author

National and Kapodistrian University of Athens

Also Known As

C Christakou, C. Christakou, Charikleia Christakou, Charikleia D Christakou, Charikleia D. Christakou, Christakou Charikleia

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Laiko General Hospital of Athens Sotiria General Hospital

About

Charikleia Christakou is an author at National and Kapodistrian University of Athens specializing in endocrinology, medicine, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	324
2	Endocrinology	8	8	324
3	Health Sciences	5	5	241
4	Public Health	2	2	61
5	Diabetes	2	2	56

Charikleia Christakou

Publications

446

Citations

H-Index

Page 1

	Year	Citations
Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS) Evangelia Tantalaki, Christina Piperi, Sarantis Livadas, HORMONES Metabolic SyndromeNutritionMetabolic ProfileBody CompositionPhysiology	2014	99
Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome Sarantis Livadas, Sofia Chaskou, Anna A. Kandaraki, Clinical Endocrinology	2011	60
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls Frangiskos Economou, Xenofon Xyrafis, Sarantis Livadas, HORMONES ObesityMetabolic SyndromeHepatologyMetabolic DisorderLiver Physiology	2009	50
Visceral adiposity index (<scp>VAI</scp>) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome Ioannis I. Androulakis, Eleni Kandaraki, Charikleia Christakou, Clinical Endocrinology	2014	39
Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander? Charikleia Christakou, Frangiskos Economou, Sarantis Livadas, HORMONES Clinical DisordersCausal RelationshipPositive AssociationPhysiologyVascular Biology	2011	36
Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Evanthia Diamanti‐Kandarakis, Charikleia Christakou, HELEN A. KANDARAKIS PubMed Metabolic DisorderReproductive HealthGynecologyPolycystic Ovary SyndromeFemale Reproductive Function	2007	35
Does polycystic ovary syndrome start in childhood? Evanthia Diamanti‐Kandarakis, Charikleia Christakou, Eleni Palioura, PubMed FertilityReproductive HealthGynecologyPathologyPolycystic Ovary Syndrome	2008	31
Polycystic ovary syndrome – Phenotypes and diagnosis Charikleia Christakou, Evanthia Diamanti‐Kandarakis Scandinavian Journal of Clinical and Laboratory Investigation Reproductive HealthGynecologyPathologyPolycystic Ovary SyndromeFemale Reproductive System	2014	30
Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents? Evanthia Diamanti‐Kandarakis, Charikleia Christakou, Eleni Kandaraki, PubMed	2007	23
The bencfit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers Charikleia Christakou, Christina Piperi, Ilias Katsikis, HORMONES ContraceptionHormonal ContraceptiveOral ContraceptivesOral ContraceptiveBencfit-to-risk Ratio	2014	22

Page 1